Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BOLDBoundless Bio, Inc.

Nasdaq · CIK 0001782303
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts194

Identity from submissions API

NameBoundless Bio, Inc.
CIK0001782303
TickersBOLD
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN830751369
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858) 766-9912
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
11099 NORTH TORREY PINES ROAD
SUITE 150
LA JOLLA
CA
92037
CA
Mailing address
11099 NORTH TORREY PINES ROAD
SUITE 150
LA JOLLA
CA
92037
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

166 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 4 xslF345X06/form4-11172026_101103.xml 0001178579-26-000025 9404
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001214659-26-014412 005-94492 261561113 34 14504
2026-11-10 4 xslF345X06/form4-11102026_101130.xml 0001178579-26-000024 9402
2026-11-10 10-Q 10-Q 0001193125-26-454406 001-41989 261537910 34 8418936 1 1
2026-11-05 4 xslF345X06/form4-11052026_111112.xml 0001178579-26-000023 11160
2026-11-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003420 333-299369 261519794 33 1768
2026-11-03 424B3 424B3 0001193125-26-445503 333-299369 261518343 33 9717485
2026-11-02 S-4/A S-4/A 0001193125-26-442255 333-299369 261509696 33 22886030 1 1
2026-10-29 4 xslF345X06/form4-10292026_101050.xml 0001178579-26-000022 7749
2026-10-26 425 425 0001193125-26-432157 001-41989 261486647 34 323276
2026-10-26 4 xslF345X06/form4-10262026_081059.xml 0001178579-26-000020 11161
2026-10-26 425 425 0001193125-26-431041 001-41989 261483560 34 39030
2026-10-20 4 xslF345X06/form4-10202026_091022.xml 0001178579-26-000019 13174
2026-10-08 S-4 S-4 0001193125-26-417903 333-299369 261449938 33 24018773 1 1
2026-08-31 DRS filename1.htm 0001193125-26-375323 377-09719 261342434 33 10806168
2026-08-28 425 425 0001193125-26-374789 001-41989 261341615 34 159122
2026-08-28 8-K 8-K 1.01,9.01 0001193125-26-374787 001-41989 261341603 34 320731 1 1
2026-08-28 4 xslF345X06/form4-08282026_080804.xml 0001178579-26-000018 7977
2026-08-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-371863 005-94492 261332576 34 7295
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097418 005-94492 261284489 34 14739
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097051 005-94492 261280904 34 18052
2026-08-07 10-Q 10-Q 0001193125-26-339093 001-41989 261251354 34 8660184 1 1
2026-07-21 4 xslF345X06/form4-07212026_110753.xml 0001178579-26-000017 10836
2026-07-16 4 xslF345X06/form4-07172026_120745.xml 0001178579-26-000015 11114
2026-07-13 4 xslF345X06/form4-07132026_110705.xml 0001178579-26-000011 11111
2026-07-08 4 xslF345X06/form4-07092026_120702.xml 0001178579-26-000010 11144
2026-07-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000622 19854
2026-07-06 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001012975-26-000621 26862
2026-07-02 4 xslF345X06/form4-07022026_110743.xml 0001178579-26-000009 12783
2026-06-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001214659-26-007864 005-94492 261137546 34 27763
2026-06-29 4 xslF345X06/form4-06292026_110657.xml 0001178579-26-000008 16215
2026-06-29 3 xslF345X06/form3-06292026_110621.xml 0001178579-26-000007 6411
2026-06-23 425 425 0001193125-26-278575 001-41989 261109017 34 1132384
2026-06-23 8-K 8-K 1.01,2.05,3.02,5.01,5.02,7.01,8.01,9.01 0001193125-26-278570 001-41989 261109002 34 1551346 1 1
2026-06-17 8-K 8-K 5.07 0001193125-26-273544 001-41989 261096952 34 201360 1 1
2026-06-15 4 4 0001193125-26-271474 5613
2026-06-15 4 4 0001193125-26-271465 5716
2026-06-15 4 4 0001193125-26-271457 5653
2026-06-15 4 4 0001193125-26-271453 5653
2026-05-08 10-Q 10-Q 0001193125-26-213321 001-41989 26956028 34 6698906 1 1
2026-05-08 8-K 8-K 2.02,9.01 0001193125-26-213269 001-41989 26956011 34 419547 1 1
2026-04-28 ARS ARS 0001193125-26-187010 001-41989 26907768 34 5343577
2026-04-28 DEFA14A DEFA14A 0001193125-26-186925 001-41989 26907558 34 1877307
2026-04-28 DEF 14A DEF 14A 0001193125-26-186884 001-41989 26907441 34 5041618 1 1
2026-04-13 8-K 8-K 1.02,2.03 0001193125-26-153076 001-41989 26858505 34 151982 1 1
2026-03-09 10-K 10-K 0001193125-26-097543 001-41989 26733167 34 25637024 1 1
2026-03-09 8-K 8-K 2.02,5.02,9.01 0001193125-26-097535 001-41989 26733160 34 483833 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001826420-26-000005 005-94492 26644443 34 14144
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000366 005-94492 26601836 34 11623
2026-01-26 4 4 0001193125-26-021658 5353
2026-01-26 4 4 0001193125-26-021657 5368
2026-01-26 4 4 0001193125-26-021656 5327
2026-01-26 4 4 0001193125-26-021655 5334
2026-01-26 4 4 0001193125-26-021654 5412
2025-12-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-118546 005-94492 251550896 34 27320
2025-11-05 10-Q 10-Q 0001193125-25-265714 001-41989 251451759 34 8014149 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-265707 001-41989 251451743 34 477976 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-022005 005-94492 251221469 34 12662
2025-08-05 10-Q 10-Q 0000950170-25-102391 001-41989 251182770 34 7686009 1 1
2025-08-05 8-K 8-K 2.02,9.01 0000950170-25-102386 001-41989 251182756 34 476560 1 1
2025-06-23 4 4 0000950170-25-089089 5513
2025-06-23 4 4 0000950170-25-089085 5495
2025-06-23 4 4 0000950170-25-089082 5456
2025-06-23 4 4 0000950170-25-089077 5558
2025-06-23 4 4 0000950170-25-089072 5474
2025-06-23 4 4 0000950170-25-089067 5455
2025-06-23 8-K 8-K 5.07 0000950170-25-089002 001-41989 251065207 34 175571 1 1
2025-05-23 8-K 8-K 2.05,8.01 0000950170-25-076911 001-41989 25982163 34 165793 1 1
2025-05-09 10-Q 10-Q 0000950170-25-067496 001-41989 25928362 34 7793980 1 1
2025-05-09 8-K 8-K 2.02,9.01 0000950170-25-067495 001-41989 25928335 34 431224 1 1
2025-04-29 ARS ARS 0000950170-25-060114 001-41989 25887467 34 10134170
2025-04-29 DEFA14A DEFA14A 0000950170-25-060089 001-41989 25887091 34 1069353
2025-04-29 DEF 14A DEF 14A 0000950170-25-060073 001-41989 25886928 34 4244681 1 1
2025-04-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001071 333-286302 25829671 33 1751
2025-04-08 CORRESP filename1.htm 0001193125-25-075712 6873
2025-04-08 UPLOAD filename1.pdf 0000000000-25-003738 333-286302 40039
2025-04-01 8-K 8-K 1.01,9.01 0001193125-25-070496 001-41989 25800361 34 156432 1 1
2025-04-01 S-3 S-3 0001193125-25-070393 333-286302 25799528 33 1007977
2025-03-27 10-K 10-K 0000950170-25-045725 001-41989 25775249 34 45838683 1 1
2025-03-27 8-K 8-K 2.02,9.01 0000950170-25-045722 001-41989 25775234 34 481236 1 1
2025-02-03 4 4 0000950170-25-012568 5409
2025-02-03 3 3 0000950170-25-012557 17386
2025-01-23 4 4 0000950170-25-008320 5269
2025-01-23 4 4 0000950170-25-008319 5241
2025-01-23 4 4 0000950170-25-008318 5220
2025-01-23 4 4 0000950170-25-008317 5248
2025-01-23 UPLOAD filename1.pdf 0000000000-25-000735 005-94492 42799
2024-12-12 8-K 8-K 5.02,7.01,8.01,9.01 0000950170-24-135768 001-41989 241544817 34 269644 1 1
2024-11-07 10-Q 10-Q 0000950170-24-123291 001-41989 241435568 34 6808205 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-123274 001-41989 241435493 34 352941 1 1
2024-10-29 SC 13D ARCH VENTURE FUND IX, L.P. - BOUNDLESS BIO -- SCH 13D 0001072613-24-000789 005-94492 241406995 34 484016
2024-10-15 3 3 0000950170-24-114468 26546
2024-10-15 8-K 8-K 5.02 0000950170-24-114466 001-41989 241369334 34 159260 1 1
2024-08-20 4 4 0000950170-24-099308 25212
2024-08-20 4 4 0000950170-24-099307 33575
2024-08-20 4 4 0000950170-24-099306 20947
2024-08-20 4 4 0000950170-24-099303 25158
2024-08-20 4 4 0000950170-24-099299 25274
2024-08-20 4 4 0000950170-24-099296 16973
2024-08-20 8-K 8-K 5.02 0000950170-24-099185 001-41989 241225979 34 152129 1 1
2024-08-12 8-K 8-K 2.02,9.01 0000950170-24-095481 001-41989 241197138 34 360773 1 1
2024-08-12 10-Q 10-Q 0000950170-24-095421 001-41989 241196859 34 6581660 1 1
2024-06-20 4 4 0000950170-24-075800 5443
2024-05-13 10-Q 10-Q 0000950170-24-058188 001-41989 24936847 34 6368311 1 1
2024-05-13 8-K 8-K 2.02,7.01,9.01 0000950170-24-058186 001-41989 24936844 34 367967 1 1
2024-04-12 SC 13G SC 13G 0001104659-24-046791 005-94492 24841806 34 91427
2024-04-12 SC 13G SC 13G 0001104659-24-046767 005-94492 24841640 34 113846
2024-04-10 SC 13G filing.txt 0000315066-24-001708 005-94492 24834457 34 8152
2024-04-09 SC 13G SC 13G 0001104659-24-045227 005-94492 24832898 34 77832
2024-04-04 4 4 0000950170-24-041844 30726
2024-04-04 4 4 0000950170-24-041843 12613
2024-04-04 4 4 0000950170-24-041842 33971
2024-04-04 4 4 0000950170-24-041841 42413
2024-04-04 4 xslF345X05/form4-04042024_040402.xml 0001415889-24-010278 26304
2024-04-02 4 xslF345X05/form4-04032024_120459.xml 0001415889-24-009885 11407
2024-04-02 8-K 8-K 5.03,8.01,9.01 0001193125-24-084736 001-41989 24814066 34 419033 1 1
2024-03-29 4 4 0000950170-24-038705 5225
2024-03-29 4 4 0000950170-24-038703 5126
2024-03-29 4 4 0000950170-24-038698 5183
2024-03-29 4 4 0000950170-24-038697 5144
2024-03-29 4 4 0000950170-24-038702 5215
2024-03-29 4 4 0000950170-24-038696 5227
2024-03-29 4 4 0000950170-24-038701 5181
2024-03-29 4 4 0000950170-24-038699 5256
2024-03-29 4 4 0000950170-24-038695 5192
2024-03-29 4 4 0000950170-24-038700 5233
2024-03-29 4 4 0000950170-24-038693 5125
2024-03-29 4 4 0000950170-24-038692 5241
2024-03-28 S-8 S-8 0001193125-24-080893 333-278354 24800586 33 291906
2024-03-28 424B4 424B4 0001193125-24-080798 333-277696 24799986 33 9444292
2024-03-27 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-03-27 16:00:00 9999999995-24-000741 333-277696 24793228 33 1764
2024-03-27 3 xslF345X02/form3-03282024_010328.xml 0001415889-24-009285 6626
2024-03-27 3 xslF345X02/form3-03282024_120342.xml 0001415889-24-009276 15860
2024-03-27 3 3 0000950170-24-037509 21945
2024-03-27 3 3 0000950170-24-037507 16773
2024-03-27 3 3 0000950170-24-037506 31775
2024-03-27 3 3 0000950170-24-037505 19088
2024-03-27 3 3 0000950170-24-037500 22258
2024-03-27 3 3 0000950170-24-037498 20661
2024-03-27 3 3 0000950170-24-037494 23008
2024-03-27 3 3 0000950170-24-037491 26003
2024-03-27 3 3 0000950170-24-037487 19811
2024-03-27 3 3 0000950170-24-037485 23683
2024-03-27 3 3 0000950170-24-037484 20247
2024-03-27 3 3 0000950170-24-037478 21788
2024-03-27 3 3 0000950170-24-037472 28627
2024-03-27 3 3 0000950170-24-037467 20059
2024-03-27 CERT 8A_CERT_BOLD.pdf 0001354457-24-000207 001-41989 24789729 34 217994
2024-03-25 CORRESP filename1.htm 0001193125-24-076458 10308
2024-03-25 CORRESP filename1.htm 0001193125-24-076457 7334
2024-03-22 8-A12B 8-A12B 0001193125-24-075413 001-41989 24776061 34 14168
2024-03-21 S-1/A S-1/A 0001193125-24-073230 333-277696 24769303 33 11277145
2024-03-15 CORRESP filename1.htm 0001193125-24-068520 24369
2024-03-13 UPLOAD filename1.pdf 0000000000-24-002778 377-06851 43910
2024-03-08 CORRESP filename1.htm 0001193125-24-063723 74342
2024-03-06 CORRESP filename1.htm 0001193125-24-060721 25421
2024-03-06 S-1 S-1 0001193125-24-060708 333-277696 24725888 33 11626503
2024-01-29 UPLOAD filename1.pdf 0000000000-24-001096 377-06851 42758
2024-01-23 DRS/A filename1.htm 0000950123-24-000290 377-06851 24550297 33 9594524
2023-10-11 DRSLTR filename1.htm 0000950123-23-008797 59122
2023-10-11 DRS/A filename1.htm 0000950123-23-008796 377-06851 231321193 33 9468794
2023-09-29 UPLOAD filename1.pdf 0000000000-23-010853 377-06851 60996
2023-09-01 DRS filename1.htm 0000950123-23-008432 377-06851 231233311 33 10764787
2023-08-15 D xslFormDX01/primary_doc.xml 06b 0001567619-23-006940 021-489721 231172982 33 10817
2021-05-04 D xslFormDX01/primary_doc.xml 06b 0001567619-21-008997 021-398232 21889671 33 10197
2020-03-12 D xslFormDX01/primary_doc.xml 06b 0001567619-20-006172 021-362715 20708706 33 11750

Latest XBRL company facts

One latest value per concept from companyfacts (194 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 23.61M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
dei EntityPublicFloat Entity Public Float USD 18.00M 2025-06-30 2025 FY 10-K 2026-03-09 0001193125-26-097543
ffd NetFeeAmt NetFeeAmt USD 0.01 2026-10-29 S-4/A 2026-11-02 0001193125-26-442255
ffd TtlFeeAmt TtlFeeAmt USD 0.04 2026-10-29 S-4/A 2026-11-02 0001193125-26-442255
ffd TtlOfferingAmt TtlOfferingAmt USD 282.23 2026-10-29 S-4/A 2026-11-02 0001193125-26-442255
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-29 S-4/A 2026-11-02 0001193125-26-442255
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0.03 2026-10-29 S-4/A 2026-11-02 0001193125-26-442255
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 814,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 559,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -19,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 364.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 6,000 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 284,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 12.30M 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 4.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap Assets Assets USD 63.59M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AssetsCurrent Assets, Current USD 63.59M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 19,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 59.08M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 59.06M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 34.91M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 62.90M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 34.91M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 16.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 8.53M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 700.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 23.11M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 23.11M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -42.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 28.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Securities 8 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 5.28M 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058188
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 12.35M 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045725
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 39,000 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 87.50M 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 15.73M 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 12.35M 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 45.57M 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.27M 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 10.12M 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 75.15M 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 12.26M 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 91,000 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap Depreciation Depreciation USD 528,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0000950170-24-095421
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058188
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.89 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.89 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.206 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0.002 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.009 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045725
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 1.14M 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.02 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.063 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.016 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.021 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 682,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 265,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 19.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 1.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap IncomeTaxExaminationInterestAccrued Income Tax Examination, Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap IncomeTaxExaminationPenaltiesAccrued Income Tax Examination, Penalties Accrued USD 0 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-09 0001193125-26-097543
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 11.97M 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -12.22M 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD -93,000 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 1,000 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -4.13M 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 1.06M 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 1.22M 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -7.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 16.30M 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -12.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap LeaseCost Lease, Cost USD 10.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap Liabilities Liabilities USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 63.59M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.87M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 886,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 62.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -46.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -42.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OperatingExpenses Operating Expenses USD 45.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -45.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OperatingLeaseCost Operating Lease, Cost USD 8.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OperatingLeasePayments Operating Lease, Payments USD 13.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.083 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 372,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OtherAssets Other Assets USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent USD 13,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -83,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -102,000 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 266,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PaymentsForRent Payments for Rent USD 2.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 3.35M 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 37.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 46,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.06 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-13 0000950170-24-058188
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 70.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 700,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 93.00M 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 99.67M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045725
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 100.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 265,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 849,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 37,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -5.36M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 25.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap RestrictedCash Restricted Cash USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -302.28M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 47.59M 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap SecurityDeposit Security Deposit USD 500 2026-06-30 S-4/A 2026-11-02 0001193125-26-442255
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.07 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 5.31M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.99 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 900,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 236,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 5.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.98M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.05 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 1.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.31M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.99 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 1.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 5.31M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 2.99 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.27 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.27 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap SharesOutstanding Shares, Outstanding shares 22.48M 2026-06-30 S-4/A 2026-11-02 0001193125-26-442255
us-gaap ShortTermInvestments Short-term Investments USD 27.98M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 61.72M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 61.72M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.05 2024-03-19 2025 Q1 10-Q 2025-05-09 0000950170-25-067496
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 35,000 2026-04-01 2026-06-30 S-4/A 2026-11-02 0001193125-26-442255
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 667,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 247.62M 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 37,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 87.69M 2024-01-01 2024-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 813,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045725
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 252.10M 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045725
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045725
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045725
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045725
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045725
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 9.87M 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 656,000 2025-01-01 2025-12-31 S-4/A 2026-11-02 0001193125-26-442255
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-045725
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 22.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 22.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-454406

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →